Donor-specific antibodies are associated with micro- and macrovascular coronary disease, restrictive myocardial damage, and poor outcome in heart-transplanted patients

Author(s):
Clemmensen, T.S.; Koefoed-Nielsen, P.; Jensen, L.A.; Poulsen, S.H.; Holm, N.R.; Logstrup, B.B.; Christiansen, E.H.; Dijkstra, J. (0000-0002-8666-3731); Valen, K.P.B.; Eiskjaer, H.
Published
2017
Publication type
Article / Letter to editor
graft survivalheart (allograft) functiondysfunctionheart disease: immuneinflammatoryrejectionvasculopathy
Date issued
2017-09-30
Language
English
Is part of
Clinical Transplantation (2017), No. 9
hdl
1887/115189
doi
10.1111/ctr.13033